Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

Ex-Deerfield partners get prison in case over U.S. agency leaks

Stock Markets Sep 13, 2018 02:21PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Rob Olan, employee of the healthcare investment fund Deerfield Management, departs Federal Court in Manhattan after an arraignment for insider trading in New York
 
VAR
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DVA
-1.37%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ARAY
-5.07%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
NXTM
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Brendan Pierson

NEW YORK (Reuters) - Two former partners of the hedge fund Deerfield Management were sentenced to three years in prison on Thursday after being convicted of taking part in what prosecutors have described as an insider trading scheme based on leaks from within a federal healthcare agency.

Rob Olan and Ted Huber were sentenced by U.S. District Judge Lewis Kaplan in Manhattan, along with two other people convicted of taking part in the scheme.

Christopher Worrall, who worked for the U.S. Centers for Medicare and Medicaid Services (CMS), was sentenced to 20 months, while David Blaszczak, founder of political consulting firm Precipio Health Strategies, was sentenced to one year and a day.

"It's a case that really calls out, in my judgment, for a significant punishment, for the purpose of deterring others," Kaplan said before imposing the sentence. Nonetheless, the judge said he was imposing a relatively lenient sentence on Blaszczak because the jail term would be a hardship for his wife, who is losing her vision, and that the other sentences were proportionately shorter as a result.

Kaplan ruled that the defendants could remain free while they appeal.

A spokesman for Deerfield also declined to comment.

Barry Berke, a lawyer for Huber, declined to comment, as did John Nathanson, a lawyer for Worrall. Lawyers for Olan and Blaszczak could not immediately be reached.

The four men were charged in May 2017 with fraud, conspiracy and misappropriating government property.

Prosecutors said that Worrall tipped Blaszczak about upcoming decisions from CMS, which determines how much government insurance programs will reimburse healthcare companies. They said Blaszczak passed the information on to Huber and Olan, who used it to make about $7 million for Deerfield.

Blaszczak had also worked at CMS and kept in touch with Worrall after he left, according to prosecutors. Worrall's illegal tips to Blaszczak included advance notice about rules cutting reimbursement rates for radiation cancer treatment and dialysis, allowing Deerfield to profit by trading in companies affected by the rules, prosecutors said.

Deerfield last year agreed to pay $4.6 million to the U.S. Securities and Exchange Commission to settle related civil claims, but did not admit or deny wrongdoing.

The companies whose stock was involved included radiation oncology companies Accuray Inc (O:ARAY) and Varian Medical Systems (N:VAR), and dialysis companies DaVita Inc (N:DVA), NxStage Medical Inc (O:NXTM), according to prosecutors.

Ex-Deerfield partners get prison in case over U.S. agency leaks
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email